Use of doxycycline prophylaxis among gay and bisexual men in Melbourne
Authors:
- 1 September 2019
- journal article
- letter
- Published by Elsevier in The Lancet HIV
- Vol. 6 (9) , e568-e569
Abstract
No abstract availableFunding Information
- Early Career Fellowship from the Australian National Health and Medical Research Council (NHMRC; 1091226)
This publication has 8 references indexed in Scilit:
- Epidemiology and prevention of sexually transmitted infections in men who have sex with men at risk of HIVThe Lancet HIV, 2019
- High Interest in Doxycycline for Sexually Transmitted Infection Postexposure Prophylaxis in a Multicity Survey of Men Who Have Sex With Men Using a Social Networking ApplicationSexually Transmitted Diseases, 2019
- Doxycycline use in MSM taking PrEPThe Lancet HIV, 2018
- Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections: Promises and PerilsACS Infectious Diseases, 2018
- Doxycycline post-exposure prophylaxis: let the debate beginThe Lancet Infectious Diseases, 2018
- Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trialThe Lancet Infectious Diseases, 2018
- Preexposure Prophylaxis to Prevent Bacterial Sexually Transmitted Infections in Men Who Have Sex With MenSexually Transmitted Diseases, 2015
- Chemoprophylaxis Is Likely to Be Acceptable and Could Mitigate Syphilis Epidemics Among Populations of Gay MenSexually Transmitted Diseases, 2011